ArticlePloS one2025
Association between average triglyceride glucose-body mass index and risk of hypertension in middle-aged and elderly Chinese: A study based on Chinese CHARLS cohort data.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of the combined triglyceride glucose-body mass index and serum IQGAP3 in appraising coronary lesion severity in type 2 diabetes.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the relationship between cumulative average triglyceride glucose-body mass index (TyG-BMI) and the risk of developing hypertension among middle-aged and elderly population.
methodsData were sourced from the 2012 and 2015 China Health and Retirement Longitudinal Study. The population was stratified into four exposure levels based on the quartiles of average TyG-BMI. Logistic regression analyses were employed to assess the associations between varying levels of average TyG-BMI and the risk of hypertension. Additionally, restricted cubic spline regression models were utilized to delineate the dose-response relationship between average TyG-BMI and hypertension. The contributions of fasting plasma glucose, triglyceride, and body mass index were quantified using weighted quantile sum regression to comprehensively elucidate the role of each component of TyG-BMI.
resultsA total of 2,841 participants aged 45 years and older were included in this study, of whom 1,302 (45.83%) were male, with a mean age of 57.63 ± 8.39 years at baseline. Throughout the follow-up period, 704 (24.78%) participants developed new onset hypertension. After adjusting for confounding variables, higher average TyG-BMI levels (from two measurements) were associated with an increased risk of developing hypertension (Q2: OR = 1.37, 95% CI = 1.04-1.80; Q3: OR = 1.93, 95% CI = 1.46-2.56; Q4: OR = 2.71, 95% CI = 2.01-3.66). The results from the restricted cubic spline regression indicated a linear association between average TyG-BMI and the risk of developing hypertension (P for association < 0.001, P for nonlinear = 0.078). Weighted quantile sum regression revealed that BMI was a significant component of TyG-BMI, with weights of 0.666 and 0.769 in 2012 and 2015, respectively.
conclusionAverage TyG-BMI emerged as an independent risk factor for new onset hypertension, exhibiting a linear correlation between the two variables. Therefore, long-term monitoring of changes in TyG-BMI should have been a critical component of hypertension prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.